Review



human phospho kinase array kit ary003  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    R&D Systems human phospho kinase array kit ary003
    Human Phospho Kinase Array Kit Ary003, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 755 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human phospho kinase array kit ary003/product/R&D Systems
    Average 96 stars, based on 755 article reviews
    human phospho kinase array kit ary003 - by Bioz Stars, 2026-05
    96/100 stars

    Images



    Similar Products

    human phospho kinase array kit ary003  (R&D Systems)
    96
    R&D Systems human phospho kinase array kit ary003
    Human Phospho Kinase Array Kit Ary003, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human phospho kinase array kit ary003/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    human phospho kinase array kit ary003 - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    proteome profiler human phospho kinase array kit ary003  (R&D Systems)
    98
    R&D Systems proteome profiler human phospho kinase array kit ary003
    Proteome Profiler Human Phospho Kinase Array Kit Ary003, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteome profiler human phospho kinase array kit ary003/product/R&D Systems
    Average 98 stars, based on 1 article reviews
    proteome profiler human phospho kinase array kit ary003 - by Bioz Stars, 2026-05
    98/100 stars
    		  Buy from Supplier
    ary003  (R&D Systems)
    98
    R&D Systems ary003
    (A) To identify downstream signalling pathways activated by HIP1 overexpression membrane A of the Human phospho-kinase array <t>(ARY003)</t> used to de-termine the relative levels of phosphorylated proteins of 46 specific kinases and substrates. Lysates were prepared from PNT1A-empty vector (EV) and PNT1A-HIP1 cell lines grown in full serum. The intensity of array spots in duplicate were analysed with ImageQUANT™ software. (B) Immunoblot of PNT1a-EV and PNT1a-HIP1 lysates for HIP1, p-STAT3(Y705) and actin. Relative levels of phosphorylation of STAT3 in PNT1a-HIP1 normalised to the control cell line after correction for equal protein loading control is displayed below blots. (C) Immunoblot of HIP1, p-STAT3(Y705) upon transient ectopic expression of GFP-HIP1 in the PNT1a-EV control for 48 hours. (D) Immunoblots of HIP1 and pSTAT3 in NIH3T3 cells transiently overexpressing HIP1. (E) Immunoblots of HIP1, p-STAT3(Y705), and p-FGFR following stable knockdown of HIP1 in PNT1a-HIP1 using shRNA compared to scrambled control. Fold changes indicated were normalised to actin. (F) WP1066 pre-treatment blocked STAT3 phosphorylation upon FGF2 stimulation in HIP1 overexpressing cells. PNT1A-HIP1 and PNT1A-EV were serum starved for 24 hours, pre-treated with DMSO or kinase inhibitors for one hour and stimulated with FGF2 (20ng/ml). Comparison of treatments with PI3K inhibitor (LY294002), Jak2 inhibitor (WP1066), MEK1/2 inhibitor (U0126), FGFR phosphorylation inhibitor (PD173074). (G) Drug treatment of PNT1A cells cultured in full serum conditions. PNT1A-EV and PNT1A-HIP1 cells cultured in full serum were treated with JAK2 kinase inhibitor (WP1066), MEK1/2 kinase inhibitor (U1026) and FGFR phosphorylation inhibitor (PD173074).
    Ary003, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ary003/product/R&D Systems
    Average 98 stars, based on 1 article reviews
    ary003 - by Bioz Stars, 2026-05
    98/100 stars
    		  Buy from Supplier
    ary003 proteome profiler  (R&D Systems)
    96
    R&D Systems ary003 proteome profiler
    (A) To identify downstream signalling pathways activated by HIP1 overexpression membrane A of the Human phospho-kinase array <t>(ARY003)</t> used to de-termine the relative levels of phosphorylated proteins of 46 specific kinases and substrates. Lysates were prepared from PNT1A-empty vector (EV) and PNT1A-HIP1 cell lines grown in full serum. The intensity of array spots in duplicate were analysed with ImageQUANT™ software. (B) Immunoblot of PNT1a-EV and PNT1a-HIP1 lysates for HIP1, p-STAT3(Y705) and actin. Relative levels of phosphorylation of STAT3 in PNT1a-HIP1 normalised to the control cell line after correction for equal protein loading control is displayed below blots. (C) Immunoblot of HIP1, p-STAT3(Y705) upon transient ectopic expression of GFP-HIP1 in the PNT1a-EV control for 48 hours. (D) Immunoblots of HIP1 and pSTAT3 in NIH3T3 cells transiently overexpressing HIP1. (E) Immunoblots of HIP1, p-STAT3(Y705), and p-FGFR following stable knockdown of HIP1 in PNT1a-HIP1 using shRNA compared to scrambled control. Fold changes indicated were normalised to actin. (F) WP1066 pre-treatment blocked STAT3 phosphorylation upon FGF2 stimulation in HIP1 overexpressing cells. PNT1A-HIP1 and PNT1A-EV were serum starved for 24 hours, pre-treated with DMSO or kinase inhibitors for one hour and stimulated with FGF2 (20ng/ml). Comparison of treatments with PI3K inhibitor (LY294002), Jak2 inhibitor (WP1066), MEK1/2 inhibitor (U0126), FGFR phosphorylation inhibitor (PD173074). (G) Drug treatment of PNT1A cells cultured in full serum conditions. PNT1A-EV and PNT1A-HIP1 cells cultured in full serum were treated with JAK2 kinase inhibitor (WP1066), MEK1/2 kinase inhibitor (U1026) and FGFR phosphorylation inhibitor (PD173074).
    Ary003 Proteome Profiler, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ary003 proteome profiler/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    ary003 proteome profiler - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    ary003 proteome profiler tm  (R&D Systems)
    96
    R&D Systems ary003 proteome profiler tm
    (A) To identify downstream signalling pathways activated by HIP1 overexpression membrane A of the Human phospho-kinase array <t>(ARY003)</t> used to de-termine the relative levels of phosphorylated proteins of 46 specific kinases and substrates. Lysates were prepared from PNT1A-empty vector (EV) and PNT1A-HIP1 cell lines grown in full serum. The intensity of array spots in duplicate were analysed with ImageQUANT™ software. (B) Immunoblot of PNT1a-EV and PNT1a-HIP1 lysates for HIP1, p-STAT3(Y705) and actin. Relative levels of phosphorylation of STAT3 in PNT1a-HIP1 normalised to the control cell line after correction for equal protein loading control is displayed below blots. (C) Immunoblot of HIP1, p-STAT3(Y705) upon transient ectopic expression of GFP-HIP1 in the PNT1a-EV control for 48 hours. (D) Immunoblots of HIP1 and pSTAT3 in NIH3T3 cells transiently overexpressing HIP1. (E) Immunoblots of HIP1, p-STAT3(Y705), and p-FGFR following stable knockdown of HIP1 in PNT1a-HIP1 using shRNA compared to scrambled control. Fold changes indicated were normalised to actin. (F) WP1066 pre-treatment blocked STAT3 phosphorylation upon FGF2 stimulation in HIP1 overexpressing cells. PNT1A-HIP1 and PNT1A-EV were serum starved for 24 hours, pre-treated with DMSO or kinase inhibitors for one hour and stimulated with FGF2 (20ng/ml). Comparison of treatments with PI3K inhibitor (LY294002), Jak2 inhibitor (WP1066), MEK1/2 inhibitor (U0126), FGFR phosphorylation inhibitor (PD173074). (G) Drug treatment of PNT1A cells cultured in full serum conditions. PNT1A-EV and PNT1A-HIP1 cells cultured in full serum were treated with JAK2 kinase inhibitor (WP1066), MEK1/2 kinase inhibitor (U1026) and FGFR phosphorylation inhibitor (PD173074).
    Ary003 Proteome Profiler Tm, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ary003 proteome profiler tm/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    ary003 proteome profiler tm - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    assays proteome profiler human phospho kinase array r d systems ary003 duolink proximity ligation assay pla  (R&D Systems)
    98
    R&D Systems assays proteome profiler human phospho kinase array r d systems ary003 duolink proximity ligation assay pla
    (A) To identify downstream signalling pathways activated by HIP1 overexpression membrane A of the Human phospho-kinase array <t>(ARY003)</t> used to de-termine the relative levels of phosphorylated proteins of 46 specific kinases and substrates. Lysates were prepared from PNT1A-empty vector (EV) and PNT1A-HIP1 cell lines grown in full serum. The intensity of array spots in duplicate were analysed with ImageQUANT™ software. (B) Immunoblot of PNT1a-EV and PNT1a-HIP1 lysates for HIP1, p-STAT3(Y705) and actin. Relative levels of phosphorylation of STAT3 in PNT1a-HIP1 normalised to the control cell line after correction for equal protein loading control is displayed below blots. (C) Immunoblot of HIP1, p-STAT3(Y705) upon transient ectopic expression of GFP-HIP1 in the PNT1a-EV control for 48 hours. (D) Immunoblots of HIP1 and pSTAT3 in NIH3T3 cells transiently overexpressing HIP1. (E) Immunoblots of HIP1, p-STAT3(Y705), and p-FGFR following stable knockdown of HIP1 in PNT1a-HIP1 using shRNA compared to scrambled control. Fold changes indicated were normalised to actin. (F) WP1066 pre-treatment blocked STAT3 phosphorylation upon FGF2 stimulation in HIP1 overexpressing cells. PNT1A-HIP1 and PNT1A-EV were serum starved for 24 hours, pre-treated with DMSO or kinase inhibitors for one hour and stimulated with FGF2 (20ng/ml). Comparison of treatments with PI3K inhibitor (LY294002), Jak2 inhibitor (WP1066), MEK1/2 inhibitor (U0126), FGFR phosphorylation inhibitor (PD173074). (G) Drug treatment of PNT1A cells cultured in full serum conditions. PNT1A-EV and PNT1A-HIP1 cells cultured in full serum were treated with JAK2 kinase inhibitor (WP1066), MEK1/2 kinase inhibitor (U1026) and FGFR phosphorylation inhibitor (PD173074).
    Assays Proteome Profiler Human Phospho Kinase Array R D Systems Ary003 Duolink Proximity Ligation Assay Pla, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/assays proteome profiler human phospho kinase array r d systems ary003 duolink proximity ligation assay pla/product/R&D Systems
    Average 98 stars, based on 1 article reviews
    assays proteome profiler human phospho kinase array r d systems ary003 duolink proximity ligation assay pla - by Bioz Stars, 2026-05
    98/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) To identify downstream signalling pathways activated by HIP1 overexpression membrane A of the Human phospho-kinase array (ARY003) used to de-termine the relative levels of phosphorylated proteins of 46 specific kinases and substrates. Lysates were prepared from PNT1A-empty vector (EV) and PNT1A-HIP1 cell lines grown in full serum. The intensity of array spots in duplicate were analysed with ImageQUANT™ software. (B) Immunoblot of PNT1a-EV and PNT1a-HIP1 lysates for HIP1, p-STAT3(Y705) and actin. Relative levels of phosphorylation of STAT3 in PNT1a-HIP1 normalised to the control cell line after correction for equal protein loading control is displayed below blots. (C) Immunoblot of HIP1, p-STAT3(Y705) upon transient ectopic expression of GFP-HIP1 in the PNT1a-EV control for 48 hours. (D) Immunoblots of HIP1 and pSTAT3 in NIH3T3 cells transiently overexpressing HIP1. (E) Immunoblots of HIP1, p-STAT3(Y705), and p-FGFR following stable knockdown of HIP1 in PNT1a-HIP1 using shRNA compared to scrambled control. Fold changes indicated were normalised to actin. (F) WP1066 pre-treatment blocked STAT3 phosphorylation upon FGF2 stimulation in HIP1 overexpressing cells. PNT1A-HIP1 and PNT1A-EV were serum starved for 24 hours, pre-treated with DMSO or kinase inhibitors for one hour and stimulated with FGF2 (20ng/ml). Comparison of treatments with PI3K inhibitor (LY294002), Jak2 inhibitor (WP1066), MEK1/2 inhibitor (U0126), FGFR phosphorylation inhibitor (PD173074). (G) Drug treatment of PNT1A cells cultured in full serum conditions. PNT1A-EV and PNT1A-HIP1 cells cultured in full serum were treated with JAK2 kinase inhibitor (WP1066), MEK1/2 kinase inhibitor (U1026) and FGFR phosphorylation inhibitor (PD173074).

    Journal: bioRxiv

    Article Title: HIP1 mediates oncogenic transformation and cancer progression through STAT3 signalling

    doi: 10.1101/2020.07.09.191734

    Figure Lengend Snippet: (A) To identify downstream signalling pathways activated by HIP1 overexpression membrane A of the Human phospho-kinase array (ARY003) used to de-termine the relative levels of phosphorylated proteins of 46 specific kinases and substrates. Lysates were prepared from PNT1A-empty vector (EV) and PNT1A-HIP1 cell lines grown in full serum. The intensity of array spots in duplicate were analysed with ImageQUANT™ software. (B) Immunoblot of PNT1a-EV and PNT1a-HIP1 lysates for HIP1, p-STAT3(Y705) and actin. Relative levels of phosphorylation of STAT3 in PNT1a-HIP1 normalised to the control cell line after correction for equal protein loading control is displayed below blots. (C) Immunoblot of HIP1, p-STAT3(Y705) upon transient ectopic expression of GFP-HIP1 in the PNT1a-EV control for 48 hours. (D) Immunoblots of HIP1 and pSTAT3 in NIH3T3 cells transiently overexpressing HIP1. (E) Immunoblots of HIP1, p-STAT3(Y705), and p-FGFR following stable knockdown of HIP1 in PNT1a-HIP1 using shRNA compared to scrambled control. Fold changes indicated were normalised to actin. (F) WP1066 pre-treatment blocked STAT3 phosphorylation upon FGF2 stimulation in HIP1 overexpressing cells. PNT1A-HIP1 and PNT1A-EV were serum starved for 24 hours, pre-treated with DMSO or kinase inhibitors for one hour and stimulated with FGF2 (20ng/ml). Comparison of treatments with PI3K inhibitor (LY294002), Jak2 inhibitor (WP1066), MEK1/2 inhibitor (U0126), FGFR phosphorylation inhibitor (PD173074). (G) Drug treatment of PNT1A cells cultured in full serum conditions. PNT1A-EV and PNT1A-HIP1 cells cultured in full serum were treated with JAK2 kinase inhibitor (WP1066), MEK1/2 kinase inhibitor (U1026) and FGFR phosphorylation inhibitor (PD173074).

    Article Snippet: The Prosphoproteome array was used according to the manufacturer’s instructions (R&D systems, # ARY003) with 400μg of protein used per membrane.

    Techniques: Over Expression, Membrane, Plasmid Preparation, Software, Western Blot, Expressing, shRNA, Comparison, Cell Culture